NCT00671112 2015-10-28Everolimus and Bortezomib in Treating Patients With Relapsed or Refractory LymphomaCase Comprehensive Cancer CenterPhase 1 Terminated30 enrolled
NCT00096005 2014-02-24Tanespimycin and Bortezomib in Treating Patients With Advanced Solid Tumors or LymphomasNational Cancer Institute (NCI)Phase 1 Terminated36 enrolled
NCT00103272 2013-06-0417-N-Allylamino-17-Demethoxygeldanamycin and Bortezomib in Treating Patients With Relapsed or Refractory Hematologic CancerNational Cancer Institute (NCI)Phase 1 Terminated74 enrolled